GINS2 and chronic myelogenous leukemia, BCR-ABL1 positive: Increased expression levels of GINS2 have been reported in many types of cancer, including thyroid cancer 20, epithelial ovarian cancer 21, cervical cancer 22, breast cancer 7, 23 and chronic myelogenous leukemia 11.